Granulocytes harvested following G-CSF-enhanced leukocyte recovery retain their functional capacity during in vitro culture for 72 hours

Journal of Hematotherapy and Stem Cell Research

Volumn 5, Issue 4, 1996, Pages 351-357

  Murea, Simona ^a   Fruehauf, Stefan ^a   Zeller, W Jens ^b   Haas, Rainer ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; COMPLEMENT COMPONENT C3 RECEPTOR; CYTOTOXIC AGENT; FC RECEPTOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GLYCOPROTEIN P 15095; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PHORBOL 13 ACETATE 12 MYRISTATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SUPEROXIDE;

ARTICLE; CASE REPORT; CELL VIABILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOPRESERVATION; GRANULOCYTE FUNCTION; HEMATOLOGIC DISEASE; HODGKIN DISEASE; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LEUKOCYTE CULTURE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RESPIRATORY BURST; SUBCUTANEOUS DRUG ADMINISTRATION;

ANTIGENS, SURFACE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD PRESERVATION; BLOOD TRANSFUSION, AUTOLOGOUS; CELL ADHESION; CELL SURVIVAL; CELLS, CULTURED; CRYOPRESERVATION; FILGRASTIM; GRANULOCYTES; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOPHENOTYPING; LEUKAPHERESIS; LEUKOCYTE TRANSFUSION; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPENIA; PHAGOCYTOSIS; RECEPTORS, IMMUNOLOGIC; RESPIRATORY BURST; SUPEROXIDES; TETRADECANOYLPHORBOL ACETATE;

EID: 0029738290     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1996.5.351     Document Type: Article

References (31)

1. Alavi, J.B., Root, R.K., Djerassi, I., et al. A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N. Engl. J. Med. 296:706, 1977.
2. Strauss, R.G. Therapeutic granulocyte transfusions in 1993. Blood 81:1675, 1993.
3. Clift, R.A. & Buckner, C.D. Granulocyte transfusions. Am. J. Med. 76:631, 1984.
4. Dutcher, J.P. The potential benefit of granulocyte transfusion therapy. Cancer Invest. 7:457, 1989.
5. Nagler, A., Naparstek, E. & Engelhard, D. Combined therapy of granulocyte transfusions, intravenous opsonins and antibiotics for gram-negative pneumonia in neutropenic cancer patients. Acta Haematol. 91:42, 1994.
6. Bhatia, S., McCullough, J., Perry, E.H., et al. Granulocyte transfusions: Efficacy in treating fungal infections in neutropenic patients following bone marrow transplantation. Transfusion 34:226, 1994.
7. Schiffer, C.A., Aisner, J., Daly, P.A., et al. Alloimmunization following prophylactic granulocyte transfusion. Blood 54:766, 1979.
8. Strauss, R.G. Granulocyte transfusion therapy. Hematol. Oncol. Clin. North Am. 8:1159, 1994.
9. Bordin, J.O., Heddle, N.M. & Blajchman, M.A. Biologic effects of leukocytes present in transfused cellular blood products. Blood 84:1703, 1994.
10. Lord, B.I., Bronchud, M.H. & Dexter, T.M. The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc. Natl. Acad. Sci. USA 86:9499, 1989.
11. Souza, L.M., Boone, T.C., Gabrilove, J., et al. Recombinant human granulocyte colony stimulating factor: Effects on normal and leukemic myeloid cells. Science 232:61, 1986.
12. Yuo, A., Kitagawa, S., Ohsaka, A., et al. Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: Potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence. Blood 74:2144, 1989.
13. Kitagawa, S., Yuo, A., Souza, L.M., et al. Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by the chemotactic peptide. Biochem. Biophys. Res. Commun. 144:1143, 1987.
14. Yuo, A., Kitagawa, S., Ohsaka, A., et al. Stimulation and priming of human neutrophils by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: Qualitative and quantitative differences. Biochem. Biophys. Res. Commun. 171:491, 1990.
15. Adachi, S., Kubota, M., Wakazono, Y., et al. Mechanism of enhancement of neutrophil survival by granulocyte colony-stimulating factor and adenine. Exp. Hematol. 21:1213, 1993.
16. Rapoport, A.P., Abboud, C.N., & DiPersio, J.F. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF): Receptor biology, signal transduction, and neutrophil activation. Blood Rev. 6:43, 1992.
17. Cohen, M.S. Molecular events in the activation of human neutrophils for microbial killing. Clin. Infect. Dis. 18(Suppl. 2):170, 1994.
18. Newburger, P.E., Chovaniec, M.E. & Cohen, H.J. Activity and activation of the granulocyte superoxide-generating system. Blood 55:85, 1980.
19. Hecker, E. Phorbol esters from croton oil: Chemical nature and biological activities. Naturwissenschaften 54:282, 1967.
20. Repine, J.E., White, J.G., Clawson, C.C., et al. The influence of phorbol myristate acetate on oxygen consumption by polymorphonuclear leukocytes. J. Lab. Clin. Med. 83:911, 1974.
21. DeChatelet, L.R., Shirley, P.S. & Johnston, R.B. Jr. Effect of phorbol myristate acetate on the oxidative metabolism of human polymorphonuclear leukocytes. Blood 47:545, 1976.
22. Demetri, G.D. & Griffin, J.D. Granulocyte colony-stimulating factor and ist receptor. Blood 78:2791, 1991.
23. Caspar, C.B., Seger, R.A., Burger, J., et al. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 82:2258, 1993.
24. Kitagawa, S., Yuo, A., Souza, L.M., et al. Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by the chemotactic peptide. Biochem. Biophys. Res. Commun. 144:1143, 1987.
25. Katoh, M., Takada, M., Nakatani, N., et al. Chemotaxis and phagocytosis of the neutrophils mobilized by granulocyte colony-stimulating factor in healthy donors for granulocyte transfusions. Am. J. Hematol. 49:96, 1995.
26. Balazovich, K.J., Almeida, H.I. & Boxer, L.A. Recombinant human G-CSF and GM-CSF prime human neutrophils for Superoxide production through different signal transduction mechanisms. J. Lab. Clin. Med. 118:576, 1991.
27. Repp, R., Valerius, T.H., Sendler, A., et al. Neutrophils express the high affinity receptor for IgG (FcγRI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor. Blood 78:885, 1991.
28. Wikman, A., Lundahl, J., Fernvik, E., et al. Altered expression of adhesion molecules (L-selectin and Mac-1) on granulocytes during storage. Transfusion 34:167, 1994.
29. Yang, H., Arnaud, F. & McGann, L.E. Cryoinjury in human granulocytes and cytoplasts. Cryobiology 29:500, 1992.
30. McCarthy, D.M., Goldman, J.M. & Peters, T.J. Biochemical studies on cryopreserved granulocytes: Possible explanations for the defects induced. Br. J. Haematol. 49:227, 1981.
31. Persidsky, M. Lysosomes as primary targets of cryoinjury. Cryobiology 8:482, 1971.